The incidentalome: A threat to genomic medicine

JAMA

Volumn 296, Issue 2, 2006, Pages 212-215

  Kohane, Isaac S ^a   Masys, Daniel R ^b   Altman, Russ B ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; DNA SEQUENCE; FALSE POSITIVE RESULT; GENOME; GENOME ANALYSIS; GENOMICS; HEALTH CARE PERSONNEL; HUMAN; INCIDENTAL FINDING; MEDICAL PRACTICE; NOTE; PHENOTYPE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33745905942     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.2.212     Document Type: Note

References (23)

1. Illes J, Kirschen M, Edwards E, et al. Incidental findings in brain imaging research. Science. 2006;311:783-784.
2. Affymetrix. http://www.affymetrix.com/products/pricing/index.affx. Accessed June 20, 2006.
3. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
4. van 't Veer LJ, Dai H, van de Vijver MJ, et al. Expression profiling predicts outcome in breast cancer. Breast Cancer Res. 2003;5:57-58.
5. Mullighan CG, Flotho C, Downing JR. Genomic assessment of pediatric acute leukemia. Cancer J. 2005;11:268-282.
6. Heller RA, Schena M, Chai A, et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A. 1997;94:2150-2155.
7. Csillag C, Nielsen OH, Borup R, Nielsen FC. Microarrays and Crohn's disease: collecting reliable information. Scand J Gastroenterol. 2005;40:369-377.
8. Ermak G, Davies KJ. Gene expression in Alzheimer's disease. Drugs Today (Barc). 2002;38:509-516.
9. Miller RM, Federoff HJ. Altered gene expression profiles reveal similarities and differences between Parkinson disease and model systems. Neuroscientist. 2005;11:539-549.
10. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet. 2006;7:55-65.
11. Rock MJ, Hoffman G, Laessig RH, Kopish GJ, Litsheim TJ, Farrell PM. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. J Pediatr. 2005;147(3 suppl):S73-S77.
12. James PA, Doherty R, Harris M, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol. 2006;24:707-715.
13. Ogino S, Wilson RB. Bayesian analysis and risk assessment in genetic counseling and testing. J Mol Diagn. 2004;6:1-9.
14. Kruglyak L. Power tools for human genetics. Nat Genet. 2005;37:1299-1300 Med.
15. Teramoto A, Hirakawa K, Sanno N, Osamura Y. Incidental pituitary lesions in 1000 unselected autopsy specimens. Radiology. 1994;193:161-164.
16. Hugosson J, Aus G, Becker C, et al. Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? a comparison of two population-based studies in Sweden. BJU Int. 2000;85:1078-1084.
17. Elias S, Annas GJ. Generic consent for genetic screening. N Engl J Med. 1994;330:1611-1613.
18. Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/Omim/ mimstats/html. Accessed June 20, 2006.
19. Kohane IS, Altman RB. Health-information altruists - a potentially critical resource. N Engl J Med. 2005;353:2074-2077.
20. Miller SM, Fleisher L, Roussi P, et al. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. J Health Commun. 2005;10(suppl 1):119-136.
21. Mouchawar J, Hensley-Alford S, Laurion S, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005;7:191-197.
22. Mouchawar J, Laurion S, Ritzwoller DP, Ellis J, Kulchak-Rahm A, Hensley-Alford S. Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Am J Manag Care. 2005;11:601-608.
23. Javitt GH. Policy implications of genetic testing: not just for geneticists anymore. Adv Chronic Kidney Dis. 2006;13:178-182.